January 16th 2024
NRX-101 is a fixed-dose combination of the broad-spectrum antibiotic D-cycloserine and lurasidone.
Expert Perspectives on Emerging CDK4/6 Inhibitor Strategies in Advanced Prostate Cancer Management Settings
View More
New York GU 17th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies
March 8-9, 2024
Register Now!
Medical Crossfire®: Expert Exchanges to Maximize Clinical Outcomes for Patients with CRPC Through Evidence-Based Personalized Therapy
View More
How the Experts Treat NMIBC During a BCG Shortage—Integrating Recent Approvals and Investigational Therapies
View More
Staying Abreast of the Prostate Cancer Treatment Paradigm From Risk Stratification to Adaptive Sequencing Strategies
View More
Everything You Need to Know About PARP Inhibitor Combinations in Prostate Cancer Care: Why? For Whom? And When?
View More
Clinical Case Vignette Series: Integrating Recent Data into Practice to Improve Outcomes in Advanced Prostate Cancer
View More
Medical Crossfire®: How Will Emerging Data Inform Treatment Planning for Patients With Prostate Cancer in the Community?
View More
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Study: Both TOT and TVT are safe, effective
June 1st 2007Results of an Italian study comparing transobturator suburethral tape (TOT) and tension-free vaginal tape (TVT) show both surgical techniques to be equally efficient at a follow-up of nearly 3 years in women suffering from stress urinary incontinence.
Sperm retrieval in NOA varicocele patients: Side matters
March 1st 2007New Orleans-When retrieving sperm from men with nonobstructive azoospermia (NOA) and associated varicocele, go for the testis on the right side. That's the bottom line advice of University of California, San Francisco investigators who evaluated whether side matters in retrieving sperm for ICSI.
Teratospermia does not affect IVF/ICSI outcomes
March 1st 2007New Orleans-Having severe teratospermia does not affect pregnancy outcomes when using in vitro fertilization with intracytoplasmic sperm injection, according to a large retrospective review presented at the American Society for Reproductive Medicine annual meeting by investigators from Weill Medical College of Cornell University, New York.
Men's dietary habits affect their infertility
March 1st 2007New Orleans-Men who are interested in fatherhood had better eat their fruits and vegetables and add soy to their diet. These dietary recommendations were recently shown to boost sperm quality in an observational study from the University of Rochester, Rochester, NY.
Prostate biopsy may affect semen parameters
March 1st 2007New Orleans-Transrectal ultrasound-guided biopsy of the prostate appears to have an immediate impact on the semen parameters of reproductive-age men, according to findings from a small study from Beth Israel Medical Center, New York. However, these effects were transient in all but one patient.
Growing data point to toxins' role in fetal anomalies
February 1st 2007Atlanta-The impact of environmental toxins on male sexual development has become a topic of keen interest among pediatric urologists, who have released a growing body of data suggesting environmental links to hypospadias, cryptorchidism, and other urinary tract anomalies and diseases. At the 2006 American Academy of Pediatrics Section on Urology annual meeting, several groups presented data on the effect of in utero exposure to endocrine disrupters on the developing fetus.
Reimbursement cuts, malpractice top urologists' concerns
December 1st 2006National Report-With another year of Medicare payment cuts looming in 2007, declining reimbursement is no surprise as the number one current concern among practicing urologists, according to an exclusive survey from Urology Times and its sister publication, Contemporary Urology. Changes in reimbursement are followed closely by malpractice, office overhead, pay for performance, and increasing regulations as the top five issues that urologists are extremely or very concerned about, the first State of the Specialty survey found.
Glickman Urological Institute expands staff
November 16th 2006Three new staff members have joined the Cleveland Clinic Glickman Urological Institute: Jeffrey Palmer, MD, is the director of minimally invasive surgery, pediatric urology; Courtenay K. Moore, MD, is a specialist in female urology; and Edmund Sabanegh, MD, is head of the section of male infertility.
Bilateral varicocelectomy improves odds of pregnancy
October 1st 2006Atlanta-Men whose infertility is due to varicocele may be able to improve the likelihood of achieving impregnation by undergoing bilateral, rather than unilateral varicocelectomy, when indicated. This was the conclusion of the authors of a Canadian study presented here at the AUA annual meeting.
Performing vasectomy reversal? Use a microscope
October 1st 2006Atlanta-If you're going to perform a vasectomy reversal, use a microscope. Despite the additional time and cost involved, microsurgical vasovasostomy is superior to the loupe-assisted macroscopic technique, findings from a recent study from Korea confirm.
Surgery more accurate in finding CF-linked anomalies
October 1st 2006Atlanta-Male patients who carry any of the 25 gene mutations related to cystic fibrosis (CF) may also have anomalies of the reproductive tract, including unilateral or bilateral absence of the vas deferens or epididymal obstruction.
Obesity is linked to infertility in men
September 21st 2006Men with increased body mass index are significantly more likely to be infertile than are normal-weight men, according to research conducted at the National Institute of Environmental Health Sciences and published in Epidemiology (2006; 17:520-3).
Tandem therapies help relieve CP/CPPS symptoms
September 1st 2006Atlanta-Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) has a huge impact on men's sexuality, but a combination of pelvic muscle trigger point release physiotherapy and relaxation training can go a long way toward improving sexual dysfunction in these men, said Rodney U. Anderson, MD, professor of urology, Stanford University School of Medicine, Stanford, CA.
Pollen extract improves pain in men with CP/CPPS
September 1st 2006Atlanta-Urologists can add one more alternative, plant-based medication to the list of intriguing possibilities for treating urologic disease. This one is a rye-pollen extract called Cernilton that showed promising results in chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) in a preliminary, placebo-controlled study from Germany.
Refined bisphosphonate schedule may offer benefit
September 1st 2006Atlanta-Bisphosphonates have already been shown to reduce loss of bone mineral density (BMD) in men undergoing androgen deprivation therapy and to reduce skeletal events and markers of bone turnover in men with metastatic prostate cancer. However, the drugs carry risks and can be expensive. That's why Dror Michaelson, MD, PhD, an assistant in medicine at Massachusetts General Hospital and instructor at Harvard Medical School, Boston, examined the effects of zoledronic acid (Zometa) in a once-annual dosing schedule that is much reduced compared with that used in past trials.
Higher paternal age influences risk of miscarriage
August 16th 2006Independent of maternal age and multiple other factors, the odds of miscarriage are significantly higher in pregnancies conceived from fathers 40 years of age or older than from fathers under 25 years of age, according to the authors of a study published in Obstetrics & Gynecology (2006; 108:369-77).
Five compounds show potential in OAB, pain syndromes
August 15th 2006Atlanta-Five new compounds-none an antimuscarinic and all in different classes-are showing potential for overactive bladder. They may also have applications in BPH, chronic prostatitis/chronic pelvic pain syndrome, and painful bladder syndrome/interstitial cystitis (PBS/IC).